Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' COLEMAN CN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 92 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Coleman, CN
      Urologic oncology: extraordinary opportunities for discovery - New initiatives in radiation oncology

      UROLOGIC ONCOLOGY
    2. Coleman, CN
      Investing in our future: Listening to those who will take us where we needto go

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    3. Coleman, CN; Cumberlin, R
      We're from the government and we're here to help you

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    4. Coleman, CN
      International Conference on Translational Research and Preclinical Strategies in Radio-Oncology (ICTR) - Conference summary

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    5. Hussey, DH; Sagerman, RH; Halberg, F; Dubey, A; Coleman, CN
      Report of the 1997 SCAROP Survey on Resident Training

      ACADEMIC RADIOLOGY
    6. Coleman, CN
      Biological basis of radiation sensitivity Part 2: Cellular and molecular determinants of radiosensitivity - Reviewed

      ONCOLOGY-NEW YORK
    7. Coleman, CN; Govern, FS; Svensson, G; Mitchell, R; Chaffey, JT
      The Harvard Joint Center for Radiation Therapy, 1968-1999: A unique concept and its relationship to the prevailing times in academic medicine

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    8. Palayoor, ST; Youmell, MY; Calderwood, SK; Coleman, CN; Price, BD
      Constitutive activation of I kappa B kinase alpha and NF-kappa B in prostate cancer cells is inhibited by ibuprofen

      ONCOGENE
    9. Coleman, CN; Mason, T; Hooker, EP; Robinson, SE
      Developmental effects of intermittent prenatal exposure to 1,1,1-trichloroethane in the rat

      NEUROTOXICOLOGY AND TERATOLOGY
    10. Coleman, CN; Mitchell, JB
      Clinical radiosensitization: Why it does and does not work

      JOURNAL OF CLINICAL ONCOLOGY
    11. D'Amico, AV; Whittington, R; Malkowicz, SB; Fondurulia, J; Chen, MH; Kaplan, I; Beard, CJ; Tomaszewski, JE; Renshaw, AA; Wein, A; Coleman, CN
      Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer

      JOURNAL OF CLINICAL ONCOLOGY
    12. Shulman, LN; Buswell, L; Riese, N; Doherty, N; Loeffler, JS; von Roemeling, RW; Coleman, CN
      Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    13. Coleman, CN
      Molecular biology in radiation oncology - Radiation oncology perspective of BRCA1 and BRCA2

      ACTA ONCOLOGICA
    14. Stevenson, MA; Zhao, MJ; Asea, A; Coleman, CN; Calderwood, SK
      Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repressRSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes

      JOURNAL OF IMMUNOLOGY
    15. PALAYOOR ST; BUMP EA; CALDERWOOD SK; BARTOL S; COLEMAN CN
      COMBINED ANTITUMOR EFFECT OF RADIATION AND IBUPROFEN IN HUMAN PROSTATE CARCINOMA-CELLS

      Clinical cancer research
    16. PALAYOOR ST; BUMP EA; CALDERWOOD SK; BARTOL S; COLEMAN CN
      COMBINED ANTITUMOR EFFECT OF RADIATION AND IBUPROFEN IN HUMAN PROSTATE CARCINOMA-CELLS

      Clinical cancer research
    17. TEICHER BA; ARA G; CHEN YN; RECHT A; COLEMAN CN
      INTERACTION OF TOMUDEX WITH RADIATION IN-VITRO AND IN-VIVO

      International journal of oncology
    18. RECHT A; COLEMAN CN; TEICHER B; ARA G; CHEN YN; LOWERY C; SMITH M
      IN-VIVO AND IN-VITRO RESULTS INDICATE THAT TOMUDEX (RALTITREXED) ACTSAS A RADIOSENSITIZER

      Annals of oncology
    19. RECHT A; COLEMAN CN; TEICHER B; ARA G; CHEN YN; LOWERY C
      IN-VIVO AND IN-VITRO RESULTS INDICATE THAT TOMUDEX (RALTITREXED) ACTSAS A RADIOSENSITIZER

      Annals of oncology
    20. Linggood, R; Govern, F; Coleman, CN
      Report from the field - A blueprint for linking academic oncology and the community

      JOURNAL OF HEALTH POLITICS POLICY AND LAW
    21. COLEMAN CN
      CHEMICAL SENSITIZERS AND PROTECTORS

      International journal of radiation oncology, biology, physics
    22. DAMICO AV; CORMACK R; TEMPANY CM; KUMAR S; TOPULOS G; KOOY HM; COLEMAN CN
      REAL-TIME MAGNETIC-RESONANCE IMAGE-GUIDED INTERSTITIAL BRACHYTHERAPY IN THE TREATMENT OF SELECT PATIENTS WITH CLINICALLY LOCALIZED PROSTATE-CANCER

      International journal of radiation oncology, biology, physics
    23. CHANG EL; LOEFFLER JS; RIESE NE; WEN PY; ALEXANDER E; BLACK PM; COLEMAN CN
      SURVIVAL RESULTS FROM A PHASE-I STUDY OF ETANIDAZOLE (SR2508) AND RADIOTHERAPY IN PATIENTS WITH MALIGNANT GLIOMA

      International journal of radiation oncology, biology, physics
    24. COLEMAN CN
      OF WHAT USE IS MOLECULAR-BIOLOGY TO THE PRACTICING RADIATION ONCOLOGIST

      Radiotherapy and oncology
    25. DAMICO AV; WHITTINGTON R; KAPLAN I; BEARD C; SCHULTZ D; MALKOWICZ SB; WEIN A; TOMASZEWSKI JE; COLEMAN CN
      CALCULATED PROSTATE CARCINOMA VOLUME - THE OPTIMAL PREDICTOR OF 3-YEAR PROSTATE-SPECIFIC ANTIGEN (PSA) FAILURE FREE SURVIVAL AFTER SURGERY OR RADIATION-THERAPY OF PATIENTS WITH PRETREATMENT PSA LEVELS OF 4-20 NANOGRAMS PER MILLILITER

      Cancer
    26. TEICHER BA; ARA G; TAKEUCHI H; COLEMAN CN
      TUMOR OXYGENATION AFTER HYPERTHERMIA IN THE RAT 13762-MAMMARY-CARCINOMA AND THE DU-145 HUMAN PROSTATE-CARCINOMA

      International journal of oncology
    27. RIESE NE; BUSWELL L; NOLL L; PAJAK TF; STETZ J; LEE DJ; COLEMAN CN
      PHARMACOKINETIC MONITORING AND DOSE MODIFICATION OF ETANIDAZOLE IN THE RTOG-85-27 PHASE-III HEAD AND NECK TRIAL

      International journal of radiation oncology, biology, physics
    28. STEVENSON MA; COLEMAN CN
      MOLECULAR-BIOLOGY .2. BENEFICIAL LIAISONS - RADIOBIOLOGY MEETS CELLULAR AND MOLECULAR-BIOLOGY

      International journal of radiation oncology, biology, physics
    29. DAMICO AV; WHITTINGTON R; KAPLAN I; BEARD C; SCHULTZ D; MALKOWICZ SB; TOMASZEWSKI JE; WEIN A; COLEMAN CN
      EQUIVALENT 5-YEAR BNED IN SELECT PROSTATE-CANCER PATIENTS MANAGED WITH SURGERY OR RADIATION-THERAPY DESPITE EXCLUSION OF THE SEMINAL-VESICLES FROM THE CLINICAL TARGET VOLUME

      International journal of radiation oncology, biology, physics
    30. JONES EL; TEICHER BA; COLEMAN CN; CALDERWOOD SK
      PROSTATE ADENOCARCINOMA APOPTOSIS IN-VIVO FOLLOWING HYPERTHERMIA TREATMENT - IN-VITRO CORRELATES AND CLINICAL IMPLICATIONS

      International journal of radiation oncology, biology, physics
    31. DUTTON SC; POMEROY SL; BILLETT AL; BARNES P; KUHLMAN C; RIESE NE; GOUMNEROVA L; SCOTT RM; COLEMAN CN; TARBELL NJ
      A PHASE-I TRIAL OF ETANIDAZOLE AND HYPERFRACTIONATED RADIOTHERAPY IN CHILDREN WITH DIFFUSE BRAIN-STEM GLIOMA

      International journal of radiation oncology, biology, physics
    32. DAMICO AV; WHITTINGTON R; KAPLAN I; BEARD C; SCHULTZ D; MALKOWICZ SB; TOMASZEWSKI JE; WEIN A; COLEMAN CN
      EQUIVALENT 5-YEAR BNED IN SELECT PROSTATE-CANCER PATIENTS MANAGED WITH SURGERY OR RADIATION-THERAPY DESPITE EXCLUSION OF THE SEMINAL-VESICLES FROM THE CTV

      International journal of radiation oncology, biology, physics
    33. HUGHESDAVIES L; TARBELL NJ; COLEMAN CN; SILVER B; SHULMAN LN; LINGGOOD R; CANELLOS GP; MAUCH PM
      STAGE IA-IIB HODGKINS-DISEASE - MANAGEMENT AND OUTCOME OF EXTENSIVE THORACIC INVOLVEMENT

      International journal of radiation oncology, biology, physics
    34. DAMICO AV; WHITTINGTON R; KAPLAN I; BEARD C; JIROUTEK M; MALKOWICZ SB; WEIN A; COLEMAN CN
      EQUIVALENT BIOCHEMICAL FAILURE-FREE SURVIVAL AFTER EXTERNAL-BEAM RADIATION-THERAPY OR RADICAL PROSTATECTOMY IN PATIENTS WITH A PRETREATMENTPROSTATE-SPECIFIC ANTIGEN OF GREATER-THAN-4-20 NG ML/

      International journal of radiation oncology, biology, physics
    35. PALAYOOR ST; BUMP EA; TEICHER BA; COLEMAN CN
      APOPTOSIS AND CLONOGENIC CELL-DEATH IN PC3 HUMAN PROSTATE-CANCER CELLS AFTER TREATMENT WITH GAMMA-RADIATION AND SURAMIN

      Radiation research
    36. HOWARD SP; PARK SJ; HUGHESDAVIES L; COLEMAN CN; PRICE BD
      SURAMIN INCREASES P53 PROTEIN-LEVELS BUT DOES NOT ACTIVATE THE P53-DEPENDENT G(1) CHECKPOINT

      Clinical cancer research
    37. COLEMAN CN
      MODULATING THE RADIATION RESPONSE

      Stem cells
    38. WONG JS; ARA G; KEYES SR; HERBST R; COLEMAN CN; TEICHER BA
      LISOFYLLINE AS A MODIFIER OF RADIATION-THERAPY

      Oncology research
    39. DAMICO AV; COLEMAN CN
      ROLE OF INTERSTITIAL RADIOTHERAPY IN THE MANAGEMENT OF CLINICALLY ORGAN-CONFINED PROSTATE-CANCER - THE JURY IS STILL OUT

      Journal of clinical oncology
    40. LAWTON CA; COLEMAN CN; BUZYDLOWSKI JW; FORMAN JD; MARCIAL VA; DELROWE JD; ROTMAN M
      RESULTS OF A PHASE-II TRIAL OF EXTERNAL-BEAM RADIATION WITH ETANIDAZOLE (SR-2508) FOR THE TREATMENT OF LOCALLY ADVANCED PROSTATE-CANCER (RTOG PROTOCOL-90-20)

      International journal of radiation oncology, biology, physics
    41. COLEMAN CN
      WILL THE RADIATION ONCOLOGIST IN THE 21ST CENTURY BE EMPLOYED FULL-TIME - RESPONSE

      International journal of radiation oncology, biology, physics
    42. COLEMAN CN; GRIFFIN TW; PROSNITZ LR; HOPPE RT; COOPER JS
      TRAINING THE RADIATION ONCOLOGIST FOR THE 21ST CENTURY

      International journal of radiation oncology, biology, physics
    43. BEARD CJ; KIJEWSKI P; BUSSIERE M; GELMAN R; GLADSTONE D; SHAFFER K; PLUNKETT M; COSTELLO P; COLEMAN CN
      ANALYSIS OF PROSTATE AND SEMINAL-VESICLE MOTION - IMPLICATIONS FOR TREATMENT PLANNING

      International journal of radiation oncology, biology, physics
    44. PALAYOOR ST; BUMP EA; SAROFF DM; DELFS JR; GEULA C; MENTONBRENNAN L; HURWITZ SJ; COLEMAN CN; STEVENSON MA
      EFFECT OF BSO AND ETANIDAZOLE ON NEUROFILAMENT DEGRADATION IN NEONATAL RAT SPINAL-CORD CULTURES

      British Journal of Cancer
    45. HLATKY L; HAHNFELDT P; TSIONOU C; COLEMAN CN
      VASCULAR ENDOTHELIAL GROWTH-FACTOR - ENVIRONMENTAL CONTROLS AND EFFECTS IN ANGIOGENESIS

      British Journal of Cancer
    46. COLEMAN CN
      CONFERENCE SUMMARY - THE 9TH INTERNATIONAL-CONFERENCE ON THE CHEMICALMODIFIERS OF CANCER-TREATMENT

      British Journal of Cancer
    47. MAUCH PM; KALISH LA; MARCUS KC; COLEMAN CN; SHULMAN LN; KRILL E; COME S; SILVER B; CANELLOS GP; TARBELL NJ
      2ND MALIGNANCIES AFTER TREATMENT FOR LAPAROTOMY STAGED IA-IIIB HODGKINS-DISEASE - LONG-TERM ANALYSIS OF RISK-FACTORS AND OUTCOME

      Blood
    48. COLEMAN CN
      NOVEL RADIATION MODIFIERS

      European journal of cancer
    49. MAUCH PM; CANELLOS GP; SHULMAN LN; SILVER B; TARBELL NJ; COME S; RABIN MS; COLEMAN CN
      MANTLE IRRADIATION ALONE FOR SELECTED PATIENTS WITH LAPAROTOMY-STAGEDIA TO IIA HODGKINS-DISEASE - PRELIMINARY-RESULTS OF A PROSPECTIVE TRIAL

      Journal of clinical oncology
    50. LOEFFLER JS; SHRIEVE DC; COLEMAN CN
      CHEMORADIATION AND ADJUVANT CHEMOTHERAPY FOR GLIOBLASTOMA - WHY DOES SO MUCH THERAPY YIELD SO LITTLE IMPROVEMENT IN SURVIVAL

      International journal of radiation oncology, biology, physics
    51. COLEMAN CN
      REPORTS OF MY DEATH [MAY BE] GREATLY EXAGGERATED - REPLY

      International journal of radiation oncology, biology, physics
    52. LEE DJ; COSMATOS D; MARCIAL VA; FU KK; ROTMAN M; COOPER JS; ORTIZ HG; BEITLER JJ; ABRAMS RA; CURRAN WJ; COLEMAN CN; WASSERMAN TH
      RESULTS OF AN RTOG PHASE-III TRIAL (RTOG-85-27) COMPARING RADIOTHERAPY PLUS ETANIDAZOLE WITH RADIOTHERAPY ALONE FOR LOCALLY ADVANCED HEAD AND NECK CARCINOMAS

      International journal of radiation oncology, biology, physics
    53. BORNSTEIN BA; HERMAN TS; HANSEN JL; BUSWELL L; ZOURANJIAN PS; FRASER SM; TEICHER BA; SVENSSON GK; COLEMAN CN
      PILOT-STUDY OF LOCAL HYPERTHERMIA, RADIATION-THERAPY, ETANIDAZOLE, AND CISPLATIN FOR ADVANCED SUPERFICIAL TUMORS

      International journal of hyperthermia
    54. LANGLEY RE; QUARTUCCIO SG; KENNEALEY PT; COLEMAN CN; BUMP EA
      EFFECT OF CELL-CYCLE STAGE, DOSE-RATE AND REPAIR OF SUBLETHAL DAMAGE ON RADIATION-INDUCED APOPTOSIS IN F9 TERATOCARCINOMA CELLS

      Radiation research
    55. PALAYOOR ST; MACKLIS RM; BUMP EA; COLEMAN CN
      MODULATION OF RADIATION-INDUCED APOPTOSIS AND G(2) M BLOCK IN MURINE T-LYMPHOMA CELLS/

      Radiation research
    56. KAPLAN I; COLEMAN CN
      VALUE OF SERIAL PROSTATE-SPECIFIC ANTIGEN DETERMINATIONS 5 YEARS AFTER RADIOTHERAPY - STEEPLY INCREASING VALUES CHARACTERIZE 80-PERCENT OF PATIENTS - REPLY

      The Journal of urology
    57. LANGLEY RE; PALAYOOR ST; COLEMAN CN; BUMP EA
      RADIATION-INDUCED APOPTOSIS IN F9 TERATOCARCINOMA CELLS

      International journal of radiation biology
    58. MARCUS KC; KALISH LA; COLEMAN CN; SHULMAN LN; ROSENTHAL DS; CANELLOS GP; MAUCH PM
      IMPROVED SURVIVAL IN PATIENTS WITH LIMITED STAGE IIIA HODGKINS-DISEASE TREATED WITH COMBINED RADIATION-THERAPY AND CHEMOTHERAPY

      Journal of clinical oncology
    59. COLEMAN CN; STEVENSON MA
      THE HALL-MARK OF MODERN RADIATION ONCOLOGY

      International journal of radiation oncology, biology, physics
    60. HERSCHER LL; KRISHNA MC; COOK JA; COLEMAN CN; BIAGLOW JE; TUTTLE SW; GONZALEZ FJ; MITCHELL JB
      PROTECTION AGAINST SR-4233 (TIRAPAZAMINE) AEROBIC CYTOTOXICITY BY THEMETAL CHELATORS DESFERRIOXAMINE AND TIRON

      International journal of radiation oncology, biology, physics
    61. BUSWELL L; RECHT A; CLARK J; RAVIKUMAR T; BUSSE PM; COLEMAN CN
      COMBINED-MODALITY THERAPY OF ESOPHAGEAL CANCER WITH RADIOTHERAPY, ETANIDAZOLE, AND CISPLATIN-FLUOROURACIL, WITH OR WITHOUT SURGERY - NEUROTOXICITY, OTHER TOXICITIES AND OUTCOME

      International journal of radiation oncology, biology, physics
    62. SHULMAN LN; BUSWELL L; KALISH LA; COLEMAN CN
      USE OF THE HYPOXIC CELL SENSITIZER ETANIDAZOLE (SR-2508) WITH INTRAVENOUS MELPHALAN AND PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA - APHARMACOKINETIC STUDY

      International journal of radiation oncology, biology, physics
    63. SHULMAN LN; GOODMAN H; BUSWELL L; MUTO M; BERKOWITZ R; TEICHER B; KUSUMOTO T; HURWITZ SJ; KALISH LA; COLEMAN CN
      PHASE-I PHARMACOKINETIC STUDY OF THE HYPOXIC CELL SENSITIZER ETANIDAZOLE WITH CARBOPLATIN AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF ADVANCEDOVARIAN-CANCER

      International journal of radiation oncology, biology, physics
    64. BEARD C; BUSWELL L; ROSE MA; NOLL L; JOHNSON D; COLEMAN CN
      PHASE-II TRIAL OF EXTERNAL-BEAM RADIATION WITH ETANIDAZOLE (SR-2508) FOR THE TREATMENT OF LOCALLY ADVANCED PROSTATE-CANCER

      International journal of radiation oncology, biology, physics
    65. RIESE NE; ALEXANDER E; LOEFFLER JS; WEN P; BLACK PM; COLEMAN CN
      PHASE-I STUDY OF ETANIDAZOLE AND RADIOTHERAPY IN MALIGNANT GLIOMA

      International journal of radiation oncology, biology, physics
    66. BUMP EA; BRAUNHUT SJ; PALAYOOR ST; MEDEIROS D; LAI LL; CERCE BA; LANGLEY RE; COLEMAN CN
      NOVEL CONCEPTS IN MODIFICATION OF RADIATION SENSITIVITY

      International journal of radiation oncology, biology, physics
    67. PALAYOOR ST; BUMP EA; MALAKER K; LANGLEY RE; SAROFF DM; DELFS JR; HURWITZ SJ; COLEMAN CN
      MODIFICATION OF THE AEROBIC CYTOTOXICITY OF ETANIDAZOLE

      International journal of radiation oncology, biology, physics
    68. TUTTLE SW; HAZARD L; KOCH CJ; MITCHELL JB; COLEMAN CN; BIAGLOW JE
      BIOREDUCTIVE METABOLISM OF SR-4233 (WIN-59075) BY WHOLE-CELL SUSPENSIONS UNDER AEROBIC AND HYPOXIC CONDITIONS - ROLE OF THE PENTOSE CYCLE AND IMPLICATIONS FOR THE MECHANISM OF CYTOTOXICITY OBSERVED IN AIR

      International journal of radiation oncology, biology, physics
    69. DOHERTY N; HANCOCK SL; KAYE S; COLEMAN CN; SHULMAN L; MARQUEZ C; MARISCAL C; RAMPLING R; SENAN S; ROEMELING RV
      MUSCLE CRAMPING IN PHASE-I CLINICAL-TRIALS OF TIRAPAZAMINE (SR-4233) WITH AND WITHOUT RADIATION

      International journal of radiation oncology, biology, physics
    70. MALAKER K; HURWITZ SJ; BUMP EA; GRIFFITH OW; LAI LL; RIESE N; COLEMAN CN
      PHARMACODYNAMICS OF PROLONGED TREATMENT WITH L,S-BUTHIONINE SULFOXIMINE

      International journal of radiation oncology, biology, physics
    71. HALBERG FE; COSMATIS D; GUNDERSON LL; NOYES RD; HANKS GR; BUSWELL L; NAGORNEY DM; COLEMAN CN
      RTOG NUMBER-89-06 - A PHASE-I STUDY TO EVALUATE INTRAOPERATIVE, RADIATION-THERAPY AND THE HYPOXIC CELL SENSITIZER ETANIDAZOLE IN LOCALLY ADVANCED MALIGNANCIES

      International journal of radiation oncology, biology, physics
    72. COLEMAN CN; BEARD CJ; KANTOFF PW; GELMAN R
      RATE OF RELAPSE FOLLOWING TREATMENT FOR LOCALIZED PROSTATE-CANCER - ACRITICAL ANALYSIS OF RETROSPECTIVE REPORTS

      International journal of radiation oncology, biology, physics
    73. COLEMAN CN
      CARCINOMA OF THE PROSTATE - PRAISING STANFORDS ACCOMPLISHMENTS

      International journal of radiation oncology, biology, physics
    74. ARA G; COLEMAN CN; TEICHER BA
      SR-4233 (TIRAPAZAMINE) ACTS AS AN UNCOUPLER OF OXIDATIVE-PHOSPHORYLATION IN HUMAN MCF-7 BREAST-CARCINOMA CELLS

      Cancer letters
    75. KAPLAN I; COLEMAN CN
      THE VALUE OF SERIAL PROSTATE-SPECIFIC ANTIGEN DETERMINATIONS 5 YEARS AFTER RADIOTHERAPY - STEEPLY INCREASING VALUES CHARACTERIZE 80-PERCENTOF PATIENTS - PROSTATE-CANCER

      The Journal of urology
    76. HLATKY L; TSIONOU C; HAHNFELDT P; COLEMAN CN
      MAMMARY FIBROBLASTS MAY INFLUENCE BREAST-TUMOR ANGIOGENESIS VIA HYPOXIA-INDUCED VASCULAR ENDOTHELIAL GROWTH-FACTOR UP-REGULATION AND PROTEIN EXPRESSION

      Cancer research
    77. STEVENSON MA; POLLOCK SS; COLEMAN CN; CALDERWOOD SK
      X-IRRADIATION, PHORBOL ESTERS, AND H2O2 STIMULATE MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVITY IN NIH-3T3 CELLS THROUGH THE FORMATION OF REACTIVE OXYGEN INTERMEDIATES

      Cancer research
    78. WEN PY; ALEXANDER E; BLACK PM; FINE HA; RIESE N; LEVIN JM; COLEMAN CN; LOEFFLER JS
      LONG-TERM RESULTS OF STEREOTAXIC BRACHYTHERAPY USED IN THE INITIAL TREATMENT OF PATIENTS WITH GLIOBLASTOMAS

      Cancer
    79. KUSUMOTO T; TEICHER BA; HOLDEN SA; COLEMAN CN; LIU SD; SOTOMAYOR EA
      REVERSAL OF DRUG-RESISTANCE BY EXPOSURE OF MCF-7 OR MCF-7 CDDP HUMAN BREAST-CARCINOMA CELLS TO SR-4233 OR ETANIDAZOLE UNDER HYPOXIC CONDITIONS

      International journal of oncology
    80. STEVENSON MA; COLEMAN CN
      BENEFICIAL LIAISONS - RADIOBIOLOGY MEETS CELLULAR AND MOLECULAR-BIOLOGY

      International journal of radiation oncology, biology, physics
    81. BEARD CJ; BUSSIERE MR; PLUNKETT ME; COLEMAN CN; KIJEWSKI PK
      ANALYSIS OF PROSTATE AND SEMINAL-VESICLE MOTION

      International journal of radiation oncology, biology, physics
    82. HERSCHER LL; KRISHNA MC; COOK J; COLEMAN CN; BIAGLOW JE; GONZALEZ FJ; MITCHELL JB
      PROTECTION AGAINST SR-4233 AEROBIC CYTOTOXICITY BY THE METAL CHELATORS DESFERRIOXAMINE AND TIRON

      International journal of radiation oncology, biology, physics
    83. TISHLER RB; CALDERWOOD SK; COLEMAN CN; PRICE BD
      DNA-DAMAGING AGENTS INCREASE SEQUENCE-SPECIFIC DNA-BINDING BY P53 (ASTRO FELLOWSHIP)

      International journal of radiation oncology, biology, physics
    84. MAUCH PM; COLEMAN CN
      MANTLE IRRADIATION ALONE FOR SELECTED PATIENTS WITH PATHOLOGICALLY STAGED (PS) IA-IIA HODGKINS-DISEASE - PRELIMINARY-RESULTS OF A PROSPECTIVE TRIAL

      International journal of radiation oncology, biology, physics
    85. BEARD CJ; KAPLAN ID; COLEMAN CN
      THE CHALLENGE FOR CONFORMAL THERAPY FOR PROSTATE-CANCER

      International journal of radiation oncology, biology, physics
    86. COLEMAN CN
      BENEFICIAL LIAISONS - RADIOBIOLOGY MEETS CELLULAR AND MOLECULAR-BIOLOGY

      Radiotherapy and oncology
    87. KELSEY KT; CAGGANA M; MAUCH PM; COLEMAN CN; CLARK JR; LIBER HL
      MUTAGENESIS AFTER CANCER-THERAPY

      Environmental health perspectives
    88. CHUSID MJ; HAVENS PL; COLEMAN CN
      ALPHA-OMEGA-ALPHA-ELECTION AND MEDICAL-SCHOOL THESIS PUBLICATION - RELATIONSHIP TO SUBSEQUENT PUBLICATION RATE OVER A 20-YEAR PERIOD

      The Yale journal of biology & medicine
    89. LANGLEY RE; PALAYOOR ST; COLEMAN CN; BUMP EA
      MODIFIERS OF RADIATION-INDUCED APOPTOSIS

      Radiation research
    90. TISHLER RB; CALDERWOOD SK; COLEMAN CN; PRICE BD
      INCREASES IN SEQUENCE-SPECIFIC DNA-BINDING BY P53 FOLLOWING TREATMENTWITH CHEMOTHERAPEUTIC AND DNA-DAMAGING AGENTS

      Cancer research
    91. COLEMAN CN; KAPLAN ID
      PROSTATE-CANCER - TECHNOLOGY VERSUS BIOLOGY

      Cancer
    92. UEMATSU M; TARBELL NJ; SILVER B; COLEMAN CN; ROSENTHAL DS; SHULMAN LN; CANELLOS G; WEINSTEIN H; MAUCH P
      WIDE-FIELD RADIATION-THERAPY WITH OR WITHOUT CHEMOTHERAPY FOR PATIENTS WITH HODGKIN DISEASE IN RELAPSE AFTER INITIAL COMBINATION CHEMOTHERAPY

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 01:05:44